Hospital Admissions, Costs, and 30-Day Readmissions Among Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran Etexilate or Warfarin

por Fonseca, Eileen, Sander, Stephen D., Hess, Gregory P., Ghosh, Sabyasachi
Publicado 2015

Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States

por Baker, William L., Cios, Deborah A., Sander, Stephen D., Coleman, Craig I.
Publicado 2009

Costs and outcomes of noncardioembolic ischemic stroke in a managed care population

por Engel-Nitz, Nicole M, Sander, Stephen D, Harley, Carolyn, Rey, Gabriel Gomez, Shah, Hemal
Publicado 2010

Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the Un...

por Jain, Rahul, Fu, An-Chen, Lim, Jonathan, Wang, Cheng, Elder, Jessica, Sander, Stephen D., Tan, Hiangkiat
Publicado 2018

Long-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial Fibrillation

por Mercaldi, Catherine J., Siu, Kimberly, Sander, Stephen D., Walker, David R., Wu, You, Li, Qian, Wu, Ning
Publicado 2012